CA Stock MarketDetailed Quotes

Fennec Pharmaceuticals Inc (FRX)

Watchlist
  • 9.280
  • -0.300-3.13%
15min DelayMarket Closed May 13 16:00 ET
322.13MMarket Cap-19.87P/E (TTM)

Fennec Pharmaceuticals Inc (FRX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-6.09%44.64M
73.84%13.78M
78.69%12.46M
32.91%9.65M
-65.52%8.75M
123.69%47.54M
-18.59%7.93M
7.05%6.97M
118.41%7.26M
1,413.24%25.38M
Operating revenue
-6.09%44.64M
258.51%9.22M
71.15%13.67M
15.58%10.94M
-60.70%10.81M
123.69%47.54M
-70.53%2.57M
15.42%7.99M
155.08%9.47M
1,540.67%27.51M
Cost of revenue
18.22%3.76M
163.68%1.76M
-51.36%660K
59.05%967K
-32.18%373K
152.90%3.18M
-2.34%669K
309.97%1.36M
310.81%608K
478.95%550K
Gross profit
-7.84%40.88M
65.56%12.01M
110.11%11.8M
30.52%8.69M
-66.25%8.38M
121.85%44.35M
-19.82%7.26M
-9.17%5.62M
109.44%6.65M
1,469.34%24.83M
Operating expense
12.77%47.22M
77.64%14.59M
10.73%12M
-2.36%11.42M
-17.16%9.2M
26.70%41.88M
-24.89%8.22M
49.04%10.84M
49.09%11.69M
60.37%11.1M
Selling and administrative expenses
13.09%46.91M
78.71%14.55M
11.57%11.96M
-1.96%11.31M
-17.95%9.09M
26.82%41.48M
-24.88%8.14M
49.14%10.72M
47.24%11.54M
61.81%11.08M
-Selling and marketing expense
1.03%18.62M
54.82%6.11M
13.24%5.21M
-6.81%4.35M
-43.42%2.95M
51.99%18.43M
1.96%3.94M
35.96%4.6M
99.66%4.67M
105.81%5.21M
-General and administrative expense
22.73%28.29M
101.17%8.44M
10.31%6.75M
1.34%6.96M
4.65%6.15M
11.99%23.05M
-39.78%4.2M
60.87%6.12M
24.91%6.86M
36.02%5.87M
Research and development costs
-18.57%250K
-60.00%20K
-70.10%29K
-31.85%107K
3,033.33%94K
448.21%307K
56.25%50K
708.33%97K
1,862.50%157K
-25.00%3K
Depreciation amortization depletion
-28.09%64K
4.00%26K
-42.86%12K
----
-35.00%13K
-68.99%89K
-64.29%25K
-70.83%21K
----
-72.22%20K
-Depreciation and amortization
-28.09%64K
4.00%26K
-42.86%12K
----
-35.00%13K
-68.99%89K
-64.29%25K
-70.83%21K
----
-72.22%20K
Operating profit
-355.99%-6.35M
-169.03%-2.58M
96.15%-201K
45.78%-2.73M
-105.98%-821K
118.98%2.48M
49.21%-959K
-379.61%-5.22M
-7.99%-5.04M
356.89%13.72M
Net non-operating interest income (expenses)
45.83%-1.29M
85.89%-80K
14.73%-434K
12.27%-436K
57.47%-356K
19.17%-2.39M
29.13%-567K
32.49%-509K
36.53%-497K
-21.48%-837K
Non-operating interest income
-53.21%787K
-42.86%228K
-70.54%152K
-70.00%171K
19.80%236K
281.41%1.68M
246.96%399K
405.88%516K
395.65%570K
80.73%197K
Non-operating interest expense
-48.88%2.08M
-68.12%308K
-42.83%586K
-43.10%594K
-42.75%592K
19.89%4.07M
5.57%966K
19.74%1.03M
26.55%1.04M
29.57%1.03M
Total other finance cost
----
----
----
-43.48%13K
-35.00%13K
-68.99%89K
-64.29%25K
-70.83%21K
-68.49%23K
-72.22%20K
Other net income (expenses)
-1,124.54%-2M
-2,050.00%-2.02M
0.00%-3K
194.12%16K
124.49%12K
-379.41%-163K
-1,666.67%-94K
87.50%-3K
-440.00%-17K
-133.33%-49K
Gain on sale of security
115.95%26K
101.06%1K
0.00%-3K
194.12%16K
124.49%12K
-379.41%-163K
-1,666.67%-94K
87.50%-3K
-440.00%-17K
-133.33%-49K
Special income (charges)
---2.02M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--2.02M
----
----
----
----
----
----
----
----
----
Income before tax
-13,470.42%-9.64M
-188.95%-4.68M
88.88%-638K
43.24%-3.15M
-109.08%-1.17M
99.56%-71K
39.60%-1.62M
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
Income tax
-70.96%106K
365K
Earnings from equity interest net of tax
Net income
-2,134.17%-9.74M
-141.16%-4.79M
88.88%-638K
43.24%-3.15M
-109.08%-1.17M
97.28%-436K
25.99%-1.99M
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
Net income continuous operations
-2,134.17%-9.74M
-141.16%-4.79M
88.88%-638K
43.24%-3.15M
-109.08%-1.17M
97.28%-436K
25.99%-1.99M
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
Noncontrolling interests
Net income attributable to the company
-2,134.17%-9.74M
-141.16%-4.79M
88.88%-638K
43.24%-3.15M
-109.08%-1.17M
97.28%-436K
25.99%-1.99M
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-2,134.17%-9.74M
-141.16%-4.79M
88.88%-638K
43.24%-3.15M
-109.08%-1.17M
97.28%-436K
25.99%-1.99M
-207.18%-5.74M
-2.00%-5.55M
312.11%12.84M
Diluted earnings per share
-1,600.00%-0.34
-183.33%-0.17
90.48%-0.02
45.00%-0.11
-108.51%-0.04
96.67%-0.02
40.00%-0.06
-200.00%-0.21
4.76%-0.2
304.35%0.47
Basic earnings per share
-1,600.00%-0.34
-183.33%-0.17
90.48%-0.02
45.00%-0.11
-109.76%-0.04
96.67%-0.02
40.00%-0.06
-200.00%-0.21
4.76%-0.2
278.26%0.41
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -6.09%44.64M73.84%13.78M78.69%12.46M32.91%9.65M-65.52%8.75M123.69%47.54M-18.59%7.93M7.05%6.97M118.41%7.26M1,413.24%25.38M
Operating revenue -6.09%44.64M258.51%9.22M71.15%13.67M15.58%10.94M-60.70%10.81M123.69%47.54M-70.53%2.57M15.42%7.99M155.08%9.47M1,540.67%27.51M
Cost of revenue 18.22%3.76M163.68%1.76M-51.36%660K59.05%967K-32.18%373K152.90%3.18M-2.34%669K309.97%1.36M310.81%608K478.95%550K
Gross profit -7.84%40.88M65.56%12.01M110.11%11.8M30.52%8.69M-66.25%8.38M121.85%44.35M-19.82%7.26M-9.17%5.62M109.44%6.65M1,469.34%24.83M
Operating expense 12.77%47.22M77.64%14.59M10.73%12M-2.36%11.42M-17.16%9.2M26.70%41.88M-24.89%8.22M49.04%10.84M49.09%11.69M60.37%11.1M
Selling and administrative expenses 13.09%46.91M78.71%14.55M11.57%11.96M-1.96%11.31M-17.95%9.09M26.82%41.48M-24.88%8.14M49.14%10.72M47.24%11.54M61.81%11.08M
-Selling and marketing expense 1.03%18.62M54.82%6.11M13.24%5.21M-6.81%4.35M-43.42%2.95M51.99%18.43M1.96%3.94M35.96%4.6M99.66%4.67M105.81%5.21M
-General and administrative expense 22.73%28.29M101.17%8.44M10.31%6.75M1.34%6.96M4.65%6.15M11.99%23.05M-39.78%4.2M60.87%6.12M24.91%6.86M36.02%5.87M
Research and development costs -18.57%250K-60.00%20K-70.10%29K-31.85%107K3,033.33%94K448.21%307K56.25%50K708.33%97K1,862.50%157K-25.00%3K
Depreciation amortization depletion -28.09%64K4.00%26K-42.86%12K-----35.00%13K-68.99%89K-64.29%25K-70.83%21K-----72.22%20K
-Depreciation and amortization -28.09%64K4.00%26K-42.86%12K-----35.00%13K-68.99%89K-64.29%25K-70.83%21K-----72.22%20K
Operating profit -355.99%-6.35M-169.03%-2.58M96.15%-201K45.78%-2.73M-105.98%-821K118.98%2.48M49.21%-959K-379.61%-5.22M-7.99%-5.04M356.89%13.72M
Net non-operating interest income (expenses) 45.83%-1.29M85.89%-80K14.73%-434K12.27%-436K57.47%-356K19.17%-2.39M29.13%-567K32.49%-509K36.53%-497K-21.48%-837K
Non-operating interest income -53.21%787K-42.86%228K-70.54%152K-70.00%171K19.80%236K281.41%1.68M246.96%399K405.88%516K395.65%570K80.73%197K
Non-operating interest expense -48.88%2.08M-68.12%308K-42.83%586K-43.10%594K-42.75%592K19.89%4.07M5.57%966K19.74%1.03M26.55%1.04M29.57%1.03M
Total other finance cost -------------43.48%13K-35.00%13K-68.99%89K-64.29%25K-70.83%21K-68.49%23K-72.22%20K
Other net income (expenses) -1,124.54%-2M-2,050.00%-2.02M0.00%-3K194.12%16K124.49%12K-379.41%-163K-1,666.67%-94K87.50%-3K-440.00%-17K-133.33%-49K
Gain on sale of security 115.95%26K101.06%1K0.00%-3K194.12%16K124.49%12K-379.41%-163K-1,666.67%-94K87.50%-3K-440.00%-17K-133.33%-49K
Special income (charges) ---2.02M------------------0----------------
-Less:Other special charges --2.02M------------------------------------
Income before tax -13,470.42%-9.64M-188.95%-4.68M88.88%-638K43.24%-3.15M-109.08%-1.17M99.56%-71K39.60%-1.62M-207.18%-5.74M-2.00%-5.55M312.11%12.84M
Income tax -70.96%106K365K
Earnings from equity interest net of tax
Net income -2,134.17%-9.74M-141.16%-4.79M88.88%-638K43.24%-3.15M-109.08%-1.17M97.28%-436K25.99%-1.99M-207.18%-5.74M-2.00%-5.55M312.11%12.84M
Net income continuous operations -2,134.17%-9.74M-141.16%-4.79M88.88%-638K43.24%-3.15M-109.08%-1.17M97.28%-436K25.99%-1.99M-207.18%-5.74M-2.00%-5.55M312.11%12.84M
Noncontrolling interests
Net income attributable to the company -2,134.17%-9.74M-141.16%-4.79M88.88%-638K43.24%-3.15M-109.08%-1.17M97.28%-436K25.99%-1.99M-207.18%-5.74M-2.00%-5.55M312.11%12.84M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -2,134.17%-9.74M-141.16%-4.79M88.88%-638K43.24%-3.15M-109.08%-1.17M97.28%-436K25.99%-1.99M-207.18%-5.74M-2.00%-5.55M312.11%12.84M
Diluted earnings per share -1,600.00%-0.34-183.33%-0.1790.48%-0.0245.00%-0.11-108.51%-0.0496.67%-0.0240.00%-0.06-200.00%-0.214.76%-0.2304.35%0.47
Basic earnings per share -1,600.00%-0.34-183.33%-0.1790.48%-0.0245.00%-0.11-109.76%-0.0496.67%-0.0240.00%-0.06-200.00%-0.214.76%-0.2278.26%0.41
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More